Gonçalo Bernardes' team, iMM Lisboa, has developed a technique that may reduce the toxicity to cancer therapies. By binding a monoclonal antibody to anti-cancer medication, therapies can be more efficiently targeted towards the tumors.
Gonçalo Bernardes' team, iMM Lisboa, has developed a technique that may reduce the toxicity to cancer therapies. By binding a monoclonal antibody to anti-cancer medication, therapies can be more efficiently targeted towards the tumors.